Author Index for Volume 18 A F S Adams, J. E., 301 Fabian, B., 92 MacMurren, M., 263 San Angel, F., 16 Frey, A. M., 280 Mancini, M. E., 307 Sater, K. J., 317 H Marx, M., 246 Senders, J. W., 28 Baranowski, L., 162 Hibberd, P. L., 65, $22 Masoorli, S., 88 Sheperd, M., 255 Bell, E., 202 Holden, J. M. C., 223 Mayes, J., 301 Smith, R. L., 255 Merante, D., 84 Staub, M. A., 202 Benvenuto, D., 166 Hunter, E. S., 202 Miller, D. D., 233 Suez, D., 178 Blum, D. Y., 116 | Murphy, D., $43 Sutherland, B. M., 292 Brown, J. M., 120 Izzo, T., 263 @] T Cc J Tenover, F. C., 297 Ombeletes, J., 326 Carter, C., 301 Jackson, D., 33 Thompkins, D. L., 111 Otto, S. E., 170 Chang, C. F., 241 Trask, K., $32 K Cook, L. S., 11 P Corbett, S., $17 Kierstead, V. L., 251 Ww Coyle, G., 202 Kramer, T., 263 Purtilo, R. B., $38 Wall, J. L., 251 Kupensky, D. T., 198 Coyne, P. J., 263 Welk, T. A., 191 L R Williams, H. F., $9 D LaRue, G. D., 24 Robathan, G., 84 Wiseman, G. R., S3 Di Girolamo, D., 79 Logan-Darrough, M., 124 Robertson, K. J., 130 Woodger, S., 84 Subject Index for Volume 18 A Bleeding disorders, 223 silicone vs. polyurethane, 120 Aides, unlicensed Bloodborne pathogens Centers for Disease Control, infec- CDC guidelines for, $32, 207 tion control guidelines of, 207 increasing use of, 326, 292 scope of practice issues and, 292 intravenous antimicrobials for, multicultural teaching of, $32 Allergic reaction $17 Central catheters to latex, 33 OSHA standards for, S9 infection rate for, 255 ethical aspects of, $38 peripherally inserted to midterm IV devices, 116 implementation of, $3, S9 breakaway system for, 92 Analgesia, for needlesticks, transcu- risk assessment for, 65, $22 in children, 280 taneous electrical nerve stim- risk management program for, placement of, 24 ulator for, 263 $43 removal of, 246, 251 Anaphylaxis Blood transfusion Chemotherapy in latex allergy, 33 leukocyte depletion in, 11 drug handling and disposal in, 16 with midterm IV devices, 116 for neonatal hyperbilirubinemia, extravasation in Antibiotics, See Antimicrobials 317 malpractice litigation and, 88 Antidotes, for chemotherapy extrav- Boards of nursing, 292 management of, 16 asation, 16 Body Substance Isolation standards, intraarterial, 170 Antifungals, mechanism of action CDC, 207 intraperitoneal, 170 ot, S17 Breakaway system, for peripherally intrathecal, 170 Antimicrobials Children, peripherally inserted cen- inserted central catheters, 92 mechanism of action of, $17 Breast-feeding, neonatal hyperbil- tral catheters for, 280 resistance to, 297, S17 irubinemia, 317 Coagulation disorders, 223 Antineoplastic drugs, See Chemo- Congestive heart failure, dobu- therapy tamine for, 100 (letter) Antivirals, mechanism of action of, Cc Culturally diverse patients, teach- $17 Cancer, chemotherapy for, See Che- ing of Universal Precautions motherapy to, $32 Catheters, See also Central cathe- Cytomegalovirus, See also Blood- Bacterial resistance, 297, $17 ters borne pathogens 334 Vol. 18, No. 6, November/December 1995 Author Index for Volume 18 A F S Adams, J. E., 301 Fabian, B., 92 MacMurren, M., 263 San Angel, F., 16 Frey, A. M., 280 Mancini, M. E., 307 Sater, K. J., 317 H Marx, M., 246 Senders, J. W., 28 Baranowski, L., 162 Hibberd, P. L., 65, $22 Masoorli, S., 88 Sheperd, M., 255 Bell, E., 202 Holden, J. M. C., 223 Mayes, J., 301 Smith, R. L., 255 Merante, D., 84 Staub, M. A., 202 Benvenuto, D., 166 Hunter, E. S., 202 Miller, D. D., 233 Suez, D., 178 Blum, D. Y., 116 | Murphy, D., $43 Sutherland, B. M., 292 Brown, J. M., 120 Izzo, T., 263 @] T Cc J Tenover, F. C., 297 Ombeletes, J., 326 Carter, C., 301 Jackson, D., 33 Thompkins, D. L., 111 Otto, S. E., 170 Chang, C. F., 241 Trask, K., $32 K Cook, L. S., 11 P Corbett, S., $17 Kierstead, V. L., 251 Ww Coyle, G., 202 Kramer, T., 263 Purtilo, R. B., $38 Wall, J. L., 251 Kupensky, D. T., 198 Coyne, P. J., 263 Welk, T. A., 191 L R Williams, H. F., $9 D LaRue, G. D., 24 Robathan, G., 84 Wiseman, G. R., S3 Di Girolamo, D., 79 Logan-Darrough, M., 124 Robertson, K. J., 130 Woodger, S., 84 Subject Index for Volume 18 A Bleeding disorders, 223 silicone vs. polyurethane, 120 Aides, unlicensed Bloodborne pathogens Centers for Disease Control, infec- CDC guidelines for, $32, 207 tion control guidelines of, 207 increasing use of, 326, 292 scope of practice issues and, 292 intravenous antimicrobials for, multicultural teaching of, $32 Allergic reaction $17 Central catheters to latex, 33 OSHA standards for, S9 infection rate for, 255 ethical aspects of, $38 peripherally inserted to midterm IV devices, 116 implementation of, $3, S9 breakaway system for, 92 Analgesia, for needlesticks, transcu- risk assessment for, 65, $22 in children, 280 taneous electrical nerve stim- risk management program for, placement of, 24 ulator for, 263 $43 removal of, 246, 251 Anaphylaxis Blood transfusion Chemotherapy in latex allergy, 33 leukocyte depletion in, 11 drug handling and disposal in, 16 with midterm IV devices, 116 for neonatal hyperbilirubinemia, extravasation in Antibiotics, See Antimicrobials 317 malpractice litigation and, 88 Antidotes, for chemotherapy extrav- Boards of nursing, 292 management of, 16 asation, 16 Body Substance Isolation standards, intraarterial, 170 Antifungals, mechanism of action CDC, 207 intraperitoneal, 170 ot, S17 Breakaway system, for peripherally intrathecal, 170 Antimicrobials Children, peripherally inserted cen- inserted central catheters, 92 mechanism of action of, $17 Breast-feeding, neonatal hyperbil- tral catheters for, 280 resistance to, 297, S17 irubinemia, 317 Coagulation disorders, 223 Antineoplastic drugs, See Chemo- Congestive heart failure, dobu- therapy tamine for, 100 (letter) Antivirals, mechanism of action of, Cc Culturally diverse patients, teach- $17 Cancer, chemotherapy for, See Che- ing of Universal Precautions motherapy to, $32 Catheters, See also Central cathe- Cytomegalovirus, See also Blood- Bacterial resistance, 297, $17 ters borne pathogens 334 Vol. 18, No. 6, November/December 1995 occupational exposures to, $22, 65 Human immunodeficiency virus, Latex allergy, anaphylaxis in, 33 transmission of, risk assessment See also Bloodborne patho- Laws, regulatory, 292 for, 65, $22 gens Leukocyte depletion, in blood trans- Cytotoxic drugs, See Chemotherapy occupational exposures to, $22, 65 fusion, 11 transmission of, risk assessment Licensure, 292 for, 65, $22 Life support, end-of-life questions D Hydrochloric acid, for implantable and, 191 Death and dying, termination of port occlusion, 198 care in, 191 Hyperbilirubinemia, neonatal, 317 Diabetes mellitus, pulsatile IV insu- Hypersensitivity lin therapy for, 124 anaphylactic, with midterm IV Malpractice Dobutamine, for congestive heart devices, 116 in infusion therapy, 88 staffing levels and, 326 failure, 100 (letter) latex, anaphylaxis in, 33 Drugs, antimicrobial Medical errors mechanism of action of, $17 detection, correction, and inter- resistance to, 297, S17 ruption of, 28 Immunoglobulin, intravenous, 178 staffing levels and, 326 Implantable port, occlusion of, hy- Medical futility, determination of, E drochloric acid for, 198 19] Economic issues, quality of care Infection Medical supplies, evaluation of, 79 and, 326 bloodborne, See Bloodborne Midterm intravenous devices, unto- Education, for Universal Precau- pathogens ward events with, 116 tions, multicultural issues in, central catheter, rates of, 255 Multicultural issues, in teaching of $32 Infection control guidelines Universal Precautions, $32 Employee exposures, to bloodborne CDC, 207 pathogens multicultural teaching of, $32 management of, $22 OSHA, S9, S38, S3 prevention of, OSHA regulations Infection transmission, risk assess- Needleless intermittent intravenous for, S9, $38, S3 ment for, 65 devices Inotrophic therapy, in home care local complications with, 202 risk assessment of, 65, $22 End-of-life questions, life support setting, 301 Needleless intermittent intravenous Insulin therapy, pulsatile IV, for di- devices, evaluation of, 54 (let- and, 191 abetes, 124 ter) Errors Intermittent intravenous devices, Needlesticks detection, correction, and inter- management of, $22 needleless, evaluation of, 54 ruption of, 28 pain management for, transcuta- (letter) staffing levels and, 326 Intraarterial chemotherapy, 170 neous electrical nerve stimu- Ethical issues Intraperitoneal chemotherapy, 170 lator for, 263 in OSHA Bloodborne Pathogen Intrathecal chemotherapy, 170 virus infection via, See Blood- Standard, $38 Intravenous access borne pathogens in termination of care, 191 intermittent vs. continuous, local Needle vs. needleless IV access, lo- Exchange transfusion, for neonatal cal complications of, 202 complications of, 202 hyperbilirubinemia, 317 needle vs. needleless, local com- Neonatal hyperbilirubinemia, 317 Extravasation plications of, 202 Nursing aides, unlicensed malpractice litigation and, 88 Intravenous extravasation increasing use of, 326, 292 management of, 16 malpractice litigation and, 88 scope of practice issues and, 292 Nursing practice regulation, 292 management of, 16 H Intravenous immunoglobulin, 178 Nutrition, total parenteral, 72-hour line change in, 84 Health care reform Intravenous needlesticks, See evolving changes in, 241 Needlesticks patient-focused care and, 307 Intravenous specialist, in health Oo role of IV specialist in, 130 care reform, 130 Occupational exposures, to blood- Hemophilia, 223 borne pathogens Hepatitis, See also Bloodborne J management of, $22 pathogens prevention of, OSHA regulations Jaundice, neonatal, 317 occupational exposures to, $22, 65 for, S9, S38, S3 transmission of, risk assessment risk assessment of, $22, 65 for, $22, 65 L Occupational Safety and Health Ad- Home care, inotrophic therapy in, Labor, preterm, tocolytic therapy ministration Bloodborne 301 for, 233 Pathogen Standard Vol. 18, No. 6, November/December 1995 ethical aspects of, $38 Preterm labor, tocolytic therapy for, Terminal illness, termination of implementation of, $9, S3 233 care in, 191 Product evaluation, 79 Tocolytic therapy, for preterm labor, p Pulsatile IV insulin therapy, for dia- 233 betes, 124 Total parenteral nutrition, 72-hour Pain management, for needlesticks, line change in, 84 transcutaneous electrical Total quality management, risk nerve stimulator for, 263 Q management and, $43 Patient-focused care, 307 Quality of care, economic factors Transcutaneous electrical nerve Patient teaching, of Universal Pre- and, 326 stimulator, for needlestick cautions, cultural issues in, pain management, 263 $32 Transfusion Pediatric peripherally inserted cen- R leukocyte depletion in, 11 tral catheters program, 280 Regional chemotherapy, 170 for neonatal hyperbilirubinemia, Peripheral intravenous devices, mid- Regulatory issues, 292 317 term, untoward events with, Risk management program Treatment, termination of, 191 116 for bloodborne pathogens, $43 Peripherally inserted central cathe- total quality management and, U ters $43 breakaway system for, 92 in children, 280 Universal Precautions, CDC, 207 infection rate for, 255 Ss multicultural teaching of, 207 placement of, 24 Scope of practice, 292 Unlicensed assistants removal of, 246, 251 Silicone catheters, vs. polyurethane increasing use of, 326, 292 scope of practice issues and, 292 Phototherapy, for neonatal hyperbil- catheters, 120 irubinemia, 317 Staffing levels, quality of care and, y Polyurethane catheters, vs. silicone 326 catheters, 120 State boards of nursing, 292 Vasovagal responses, to midterm IV Port occlusion, hydrochloric acid devices, 116 for, 198 Vesicant extravasation, management T Poster presentation, 111 of, 16 Presidential Address, 162 Teaching, of Universal Precautions, malpractice litigation and, 88 Presidential Report, 166 cultural issues in, $32 Von Willebrand disease, 223 CLASSIFIED AD SECTION Products Positions available advertising is available in JOURNAL OF INTRAVENOUS NURSING. Each line is $12.00 and all advertisements are subject to a minimum charge of $65 NED-CHEST VASCULAR ACCESS DEVICE TRAINING Service charge for a blind box number is $12.00 AID. Hands-on practice on realistic adult torso for nurses, Prepayment is not required patients, caregivers. Includes functional simulated long term A line consists of 45 characters central venous catheter, blood and fluid reservoirs, latex cov- Copy is subject to acceptance by the publisher ered IVAD receptacle. Basic training in site care, |.V. hook- JOURNAL OF INTRAVENOUS NURSING is a bimonthly journal ups, heparin flushes. $170. ELEKTRO ASSEMBLIES. (800) Copy must be received by the 1st of the month preceding month of issue 533-1558. Advertisements must be sent, TYPED, to JOURNAL OF INTRAVENOUS NURSING c/o Lippincott-Raven Publishers Attention: Ronna Ekhouse 227 East Washington Square VENI-DOT PHLEBOTOMY TRAINING DEVICE builds con- Philadelphia, PA 19106-3780 (215) 238-4215 or Fax (215) 238-4493 fidence and skill before patient contact. Practice basic venipuncture. |.V. technique on realistic simulation, immedi- Display space such as % page, % page is also available for those desiring greater visibility ate feedback unlimited practice. Two different size veins. Adjustable difficulty. Self contained, lightweight, portable. NO CANCELLATIONS WILL BE ACCEPTED AFTER ISSUE CLOSING DATE. $46.60. ELEKTRO ASSEMBLIES, INC. (800) 533-1558. Vol. 18, No. 6, November/December 1995 ae